Porter, Joshua K. http://orcid.org/0000-0002-1641-4625
Di Tanna, Gian Luca
Lipton, Richard B.
Sapra, Sandhya
Villa, Guillermo
Funding for this research was provided by:
Amgen (Europe) GmbH
Article History
First Online: 30 October 2018
Compliance with Ethical Standards
:
: The three trials used in this study were registered with ClinicalTrials.gov, numbers NCT02456740, NCT02483585 and NCT02066415, as previously reported [CitationRef removed, CitationRef removed, CitationRef removed]. The studies were approved by the Institutional Review Board/Independent Ethics Committee (IRB/IEC). The participants provided written informed consent before enrolment.
: Funding for this support was provided by Amgen (Europe) GmbH.
: JKP and GLDT are Amgen employees. SS and GV are employed by Amgen and have stock in Amgen. RBL is the Edwin S. Lowe Professor of Neurology at the Albert Einstein College of Medicine in New York. He receives research support from the NIH: 2PO1 AG003949 (Program Director), 5U10 NS077308 (PI), 1RO1 AG042595 (Investigator), RO1 NS082432 (Investigator), K23 NS09610 (Mentor), K23AG049466 (Mentor). He also receives support from the Migraine Research Foundation and the National Headache Foundation. He serves on the editorial board of <i>Neurology</i> and as senior advisor to <i>Headache</i>. He has reviewed for the National Institute on Aging and National Institute of Neurological Disorders and Stroke; holds stock options in eNeura Therapeutics and Biohaven Holdings; and serves as a consultant and/or advisory board member or has received honoraria from the American Academy of Neurology, Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Biohaven, Biovision, Boston Scientific, Dr. Reddy’s, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKline, Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, and Vedanta. He receives royalties from <i>Wolff’s Headache</i>, 8th Edition, Oxford Press University, 2009, Wiley and Informa.